# A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas

> **NCT00734682** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 34 (actual)

## Conditions studied

- Glioblastoma
- Gliosarcoma
- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma

## Interventions

- **DRUG:** Nanoliposomal CPT-11

## Key facts

- **NCT ID:** NCT00734682
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2015-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734682, "A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00734682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*